Clinical Trials Contact Us Careers Search BioMarin to Participate in Two Upcoming Virtual Investor Conferences - Evercore ISI 4th Annual HealthCONx Conference on December 1 at 1:25pm ET - Piper Sandler 33rd Annual Healthcare Conference on December 2 at 1:30pm ET Nov 29, 2021 SAN RAFAEL, Calif., Nov. 29, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in two upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference. About BioMarin BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The Company's portfolio consists of several commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit www.biomarin.com. Information on such website is not incorporated by reference into this press release. Contacts: Investors Media Traci McCarty Debra Charlesworth BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc. (415) 455-7558 (415) 455-7451 SOURCE BioMarin Pharmaceutical Inc. Navigate Our Motivation Our Treatments Our Company Investors & Media About Our History Our Products Our Pipeline Leadership Team Board of Directors Diversity, Equity & Inclusion Contact Global Contact Information Our Locations Report a Product Complaint Report Adverse Event Publication Data Request Funding & Support Connect Careers LinkedIn Facebook Instagram YouTube Privacy Policy Terms of Use Site Map Supplier Information Slavery Act Statement Glossary Contact Us © 2021 BioMarin. All rights reserved. You may delete or block cookies by accessing your preferences. For more information, please see our Privacy Policy and Terms and Conditions. By using this website, you consent to our use of cookies.Accept